Sharenet Sites 
Sharenet Sites
Directors' dealings in Adcorp securities
Adcorp Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1974/001804/06)
Share code: ADR ISIN: ZAE000000139
(“Adcorp”)
Directors’ dealings in Adcorp securities
In compliance with paragraphs 3.63 to 3.66 of the JSE Limited Listings
Requirements, the following information is disclosed in respect of an off-
market exercise of Performance Shares (PFs) and subsequent purchase of
Adcorp ordinary shares and/or subsequent cash settlement:
Name of director: RL Pike
Date of transaction: 15 June 2015
Nature of transaction: Exercise of PFs and subsequent
purchase of Adcorp ordinary shares
Number of securities: 265 500
Type and class of securities issued: Ordinary shares
Allocated Price: per table
Total value: R14 850 000.00
Period of vesting: per table
Vesting date: per table
Purchase price: per table
Nature of interest: Direct Beneficial
Clearance received: Yes
Instrument Quantity Allocated Conversion Period Vesting Purchase
Price into of date Price
ordinary vesting
shares
PFs 450 000 31.18 265 500 2 years 28 33.00
February
2015
Total 265 500
Name of director: PC Swart
Date of transaction: 15 June 2015
Nature of transaction: Exercise of PFs and subsequent
purchase of Adcorp ordinary shares
Number of securities: 243 375
Type and class of securities issued: Ordinary shares
Allocated Price: per table
Total value: R13 612 500.00
Period of vesting: per table
Vesting date: per table
Purchase price: per table
Nature of interest: Direct Beneficial
Clearance received: Yes
Instrument Quantity Allocated Conversion Period Vesting Exercise
Price into of date Price
ordinary vesting
shares
PFs 412 500 31.18 243 375 2 years 28 33.00
February
2015
Total 243 375
Name of director: AM Sher
Date of transaction: 15 June 2015
Nature of transaction: Exercise of PFs and part subsequent
purchase of Adcorp ordinary shares
and part cash settlement
Number of securities: 75 000
Type and class of securities issued: Ordinary shares
Allocated Price: per table
Total value: R4 785 000.00
Period of vesting: per table
Vesting date: per table
Purchase price: per table
Nature of interest: Direct Beneficial
Clearance received: Yes
Instrument Quantity Allocated Conversion Period Vesting Exercise/
Price into of date Purchase
ordinary vesting Price
shares*
PFs 145 000 31.18 75 000 2 years 28 33.00
February
2015
Total 75 000
*In respect of 17 881 PFs, no Adcorp shares were issued. Participant
was cash settled.
Name of director of major subsidiary: MA Jurgens
Date of transaction: 15 June 2015
Nature of transaction: Exercise of PFs and subsequent cash
settlement
Number of securities: nil
Type and class of securities issued: Ordinary shares
Allocated Price: per table
Total value: R3 465 000.00
Period of vesting: per table
Vesting date: per table
Purchase price: per table
Nature of interest: Direct Beneficial
Clearance received: Yes
Instrument Quantity Allocated Conversion Period Vesting Purchase
Price into of date Price
ordinary vesting
shares*
PFs 105 000 31.18 nil 2 years 28 33.00
February
2015
Total nil
*no Adcorp ordinary shares were issued. Employee was cash settled.
Name of director of major subsidiary: C Bomela
Date of transaction: 15 June 2015
Nature of transaction: Exercise of PFs and subsequent cash
settlement
Number of securities: nil
Type and class of securities issued: Ordinary shares
Allocated Price: per table
Total value: R3 795 000.00
Period of vesting: per table
Vesting date: per table
Purchase price: per table
Nature of interest: Direct Beneficial
Clearance received: Yes
Instrument Quantity Allocated Conversion Period Vesting Purchase
Price into of date Price
ordinary vesting
shares*
PFs 115 000 31.18 nil 2 years 28 33.00
February
2015
Total nil
*no Adcorp ordinary shares were issued. Employee was cash settled.
17 June 2015
Bryanston
Sponsor : Deloitte & Touche Sponsor Services (Pty) Ltd
Date: 17/06/2015 02:29:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
